Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.
Han JC, Xu F, Chen N, Qi GB, Wei YJ, Li HB, Zhang YJ, Li JH, Wang XL, Xu W, Li XF, Jin LF, Jia JY, Ma ZS.
Han JC, et al. Among authors: xu f, xu w.
J Cancer Res Ther. 2016 Jan-Mar;12(1):340-9. doi: 10.4103/0973-1482.154926.
J Cancer Res Ther. 2016.
PMID: 27072261
Free article.